Post-authorization Safety Surveillance Program for Sarilumab using existing European Rheumatoid Arthritis Registries in Germany, Spain, Sweden and United Kingdom

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Sweden National Prescribed Drugs Register / Läkemedelsregistret

  British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

  Rheumatoid Arthritis - Observation of Biologic Therapies
• Data source(s), other:
  ARTIS Sweden, BIOBADASER Spain
• Data sources (types):
  Disease registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Yes
• Check completeness:
  Yes
• Check stability:
  Yes
• Check logical consistency:
  Yes

Data characterisation

• Data characterisation conducted:
  Unknown